Latest Videos

In this Teach Me in 10, Lucy Lawrence and Amy Kauffman will cover what extracellular vesicles (EVs) are, the therapeutic promise they hold as well as guidance on how to culture and scale.

PLATINUM is a new study investigating a potential treatment for people who have been diagnosed with monkeypox.

In less than 10 minutes, Professor Andrew Zydney covers: What are biopharmaceuticals? How do they differ from traditional small-molecule pharmaceuticals? How are they made? What factors might influence the high cost of biopharmaceuticals?

There are raising concerns about the impact of pesticides on health and the environment. The EU-funded ChemPrime project offers a viable alternative. A new technology that, like a vaccine, prepares crops’ immune system enabling them to mount a faster and stronger immune response against future attack.

The Cancer Research Institute hosted a special event with mRNA vaccine pioneers and 2021 Coley Award Winners Katalin Karikó, Ugur Sahin, Özlem Türeci and Drew Weissman. In this interview, the honorees shared their thoughts on how mRNA vaccine technology will transform cancer treatment in the future.

Sartorius introduces the Mycap® CCX cell culture expansion system. It is designed for aseptic cell culture expansion outside a laminar flow hood with no risk of contamination.

In this episode of Teach Me in 10, Dr. Jeanita Pritchett, who has a deep-rooted passion for helping others find excitement in STEM and considers herself a "Jane of All Trades", will speak about what diversity means, why DEI policies and practices are an important factor in optimizing the science ecosystem and she seeks to address the question what everyone can do to help get us to a more inclusive environment.

Recently, Brigham and Women’s Hospital in Boston launched the first human trial of a nasal vaccine for Alzheimer’s disease. Lead researcher Dr. Howard Weiner discusses the science behind the vaccine and how it could introduce new ways of treating other neurodegenerative diseases in the future.

Speaking at Advances in Proteomics and Metabolomics 2021, Jeffrey Spraggins, Research Assistant Professor from Vanderbilt, discusses developing new, high-performance technologies for improving spatial resolution, sensitivity and specificity of MALDI IMS.

Thermo Scientific™ MAM 2.0 is a single, unified workflow that bridges the gap between development and manufacturing, through an enterprise ecosystem built on common software and hardware platforms.